CAS: 1357072-61-7
c-Met inhibitor 1
CAS:1357072-61-7
c-Met inhibitor 1 is a c-Met receptor signaling pathway inhibitor, used for the treatment of …
Formula:
C17H14N8S
Purity:
98.77%
Color and Shape:
Solid
Molecular weight:
362.41
Ref: TM-T10655
1mg | 83.00 € | ||
5mg | 170.00 € | ||
10mg | 233.00 € | ||
25mg | 388.00 € | ||
50mg | 577.00 € | ||
100mg | 820.00 € | ||
1mL*10mM (DMSO) | 187.00 € |
Estimated delivery in United States, on Tuesday 7 Jan 2025
Ref: IN-DA009CAK
25mg | 164.00 € | ||
50mg | 187.00 € | ||
100mg | 295.00 € | ||
250mg | 472.00 € |
Estimated delivery in United States, on Tuesday 7 Jan 2025
6-(1-METHYL-1H-PYRAZOL-4-YL)-3-((2-METHYL-2H-INDAZOL-5-YL)THIO)-[1,2,4]TRIAZOLO[4,3-B]PYRIDAZINE
CAS:1357072-61-7
Purity:
95.0%
Molecular weight:
362.4200134277344
Ref: 10-F390260
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire | ||
250mg | To inquire |
Estimated delivery in United States, on Tuesday 14 Jan 2025
6-(1-Methyl-1H-pyrazol-4-yl)-3-((2-methyl-2H-indazol-5-yl)thio)-[1,2,4]triazolo[4,3-B]pyridazine
CAS:1357072-61-7
6-(1-Methyl-1H-pyrazol-4-yl)-3-((2-methyl-2H-indazol-5-yl)thio)-[1,2,4]triazolo[4,3-B]pyridazine is a cMET inhibitor that blocks the activation of cMET. It has been shown …
Formula:
C17H14N8S
Purity:
Min. 95%
Molecular weight:
362.42 g/mol
Ref: 3D-HEC07261
1mg | Discontinued | Request information | |
5mg | Discontinued | Request information | |
10mg | Discontinued | Request information | |
25mg | Discontinued | Request information | |
50mg | Discontinued | Request information |